USFDA

Strides Shasun receives USFDA approval for Ibuprofen OTC Tablets

Product further strengthens Strides Ibuprofen franchise for the US markets  Bangalore, July 04, 2018: Strides Shasun Limited today announced that…

6 years ago

BioLIVE report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve bio process manufacturing efficiency

Experts warn bio industry needs to do more to create a sustainable pipeline of talent Amsterdam, June 29, 2018: A report…

6 years ago

Cipla gets USFDA nod for generic HIV drug

New Delhi, June 20, 2018: Drug major Cipla on Tuesday said it has received approval from the US health regulator to market Efavirenz…

7 years ago

Alembic Pharma receives USFDA approval for Bupropion Hydrochloride tablets

Mumbai, June 13, 2018: Pharma major, Alembic Pharmaceuticals has received approval from the United States Food and Drug Administration (USFDA)…

7 years ago

USFDA conducts cGMP audit at Cipla’s Indore formulations facility

Mumbai, April 21,2018: Pharma Major, Cipla Ltd ssaid that US Food and Drug Administration (USFDA) has conducted a routine current Good…

7 years ago

Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Ointment, 0 1 pc

Mumbai, April 21, 2018: Pharma Major.Glenmark Pharmaceuticals on Wednesday said that Glenmark Pharmaceuticals Inc USA has received final approval from…

7 years ago

Alembic Pharma receives USFDA approval for Acyclovir ointment

Mumbai, April 16, 2018: Pharma Major, Alembic Pharma said that it has received USFDA approval for its Abbreviated New Drug…

7 years ago

Panacea Biotec Ltd receives EIR from USFDA for Oncology plant at Malpur, Baddi

Mumbai, March 15, 2018: Pharma Major, Panacea Biotec Ltd. has announced the receipt of Establishment Inspection Report (EIR) from the…

7 years ago

Sun Pharma’s travails with US regulator may drag on

Mumbai, March 08, 2018: Sun Pharmaceutical’s troubles with the US drug regulator will continue, as details of the recent observations…

7 years ago

Aurobindo Pharma clarifies on Form 483 issued by USFDA for Unit 4 at Pashamylaram, Hyderabad

Mumbai, March 07, 2018: Pharma Major, Aurobindo Pharma clarifies on News Items on Company unit 4 getting 9 observation after USFDA…

7 years ago